Sign in
4

Changes in Ownership

Foghorn Therapeutics Inc. Filed Acc 0001562180-23-000727

Options or other derivatives

  • Chief Strategy/Bus Ops Officer acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cavalie Fanny Chief Strategy/Bus Ops Officer 2023-01-26 Grant or award · Stock Option (right to buy) +65,000 65,000 D
Loading xslF345X03/primarydocument.xml…